References
- SiegelRWardEBrawleyOCancer Statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deathsCA Cancer J Clin201161421223621685461
- LiauwSLWeichselbaumRRRashCBiochemical control and toxicity after intensity-modulated radiation therapy for prostate cancerTechnol Cancer Res Treat20098320120619445537
- SkalaMRosewallTDawsonLPatient-assessed late toxicity rates and principal component analysis after image-guided radiation therapy for prostate cancerInt J Radiat Oncol Biol Phys200768369069817379434
- ChungHTXiaPChanLWDoes image-guided radiotherapy improve toxicity profile in whole pelvic-treated high-risk prostate cancer? Comparison between IG-IMRT and IMRTInt J Radiat Oncol Biol Phys2009731536018501530
- NiehausAMerrickGSButlerWMThe influence of isotope and prostate volume on urinary morbidity after prostate brachytherapyInt J Radiat Oncol Biol Phys200664113614316198062
- GelblumDYPottersLAshleyRUrinary morbidity following ultrasound-guided transperineal prostate seed implantationInt J Radiation Oncology Biol Phys19994515967
- ThomasCKeyesMLiuMSegmental urethral dosimetry and urinary toxicity in patients with no urinary symptoms before permanent prostate brachytherapyInt J Radiat Oncol Biol Phys200872244745518395357
- KaplanIMinimizing rectal and urinary complications in prostate brachytherapyJ Endourol200014438138310910156
- PinkawaMFischedickKAsadpourBToxicity profile with a large prostate volume after external beam radiotherapy for localized prostate cancerInt J Radiat Oncol Biol Phys2008701838917855010
- AizerAAAndersonNSOhSCThe impact of pretreatment prostate volume on severe acute genitourinary toxicity in prostate cancer patients treated with intensity-modulated radiation therapyInt J Radiat Oncol Biol Phys201179237938420452135
- LockeJEllisWWallnerKRisk factors for acute urinary retention requiring temporary intermittent catheterization after prostate brachytherapy: a prospective studyInt J Radiat Oncol Biol Phys200252371271911849794
- KoppRDuffMCatalfamoFVMAT vs 7-field-IMRT: assessing the dosimetric parameters of prostate cancer treatment with a 292-patient sampleMedical Dosimetry20113636537221377863
- Common Terminology Criteria for Adverse Events and Common Toxicity CriteriaNational Cancer Institute Cancer Therapy Evaluation Program Available from: http://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htmAccessed October 10, 2012
- SherertzTWallnerKWangHLong-term urinary function after transperineal brachytherapy for patients with large prostate glandsInt J Radiat Oncol Biol Phys20015151241124511728683
- BlackLGroveAMorrillBThe psychometric validation of a US English satisfaction measure for patients with benign prostatic hyperplasia and lower urinary tract symptomsHealth Qual Life Outcomes200975519545384
- BarryMJFowlerFJJrO’LearyMPThe American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological AssociationJ Urol19921485154915571279218
- EadeTNHorwitzEMRuthKA comparison of acute and chronic toxicity for men with low-risk prostate cancer treated with intensity-modulated radiation therapy or 125I permanent implantInt J Radiat Oncol Biol Phys200871233834518207665
- MohammedNKestinLGhilezanMComparison of acute and late toxicities for three modern high-dose radiation treatment techniques for localized prostate cancerInt J Radiat Oncol Biol Phys201282120421221167653
- MalikRJaniABLiauwSLExternal beam radiotherapy for prostate cancer: urinary outcomes for men with high International Prostate Symptom Scores (IPSS)Int J Radiat Oncol Biol Phys20118041080108620643513
- MarksLSTreatment of men with minimally symptomatic benign prostatic hyperplasia-pro: the argument in favorUrology200362578178314624893
- MarksLBCarrollPRDuganTCThe response of the urinary bladder, urethra, and ureter to radiation and chemotherapyInt J Radiat Oncol Biol Phys1995315125712807713787
- SugimuraKCarringtonBMQuiveyJMPostirradiation changes in the pelvis: assessment with MR imagingRadiology199017538058132343132
- RoeskeJCFormanJDMesinaCFEvaluation of changes in the size and location of the prostate, seminal vesicles, bladder, and rectum during a course of external beam radiation therapyInt J Radiat Oncol Biol Phys1995335132113297493857
- ZechmannCMAftabKDidingerBChanges of prostate gland volume with and without androgen deprivation after intensity modulated radiotherapy – a follow-up studyRadiother Oncol200990340841218950882
- ZechmannCMSimpfendorferTGieselFLComparison of peripheral zone and central gland volume patients undergoing intensity-modulated radiotherapyJ Comput Assist Tomogr201034573974520861778
- CrawfordEDKavanaghBDThe role of α-blockers in the management of lower urinary tract symptoms in prostate cancer patients treated with radiation therapyAm J Clin Oncol200629551752317023790
- ZelefskyMJGinorRXFuksZEfficacy of selective alpha-1 blocker therapy in the treatment of acute urinary symptoms during radiotherapy for localized prostate cancerInt J Radiat Oncol Biol Phys199945356757010524407
- ProsnitzRGSchneiderLManolaJTamsulosin palliates radiation-induced urethritis in patients with prostate cancer: results of a pilot studyInt J Radiat Oncol Biol Phys199945356356610524406